Sami Corwin
Stock Analyst at William Blair
(0.09)
# 4,473
Out of 5,179 analysts
11
Total ratings
16.67%
Success rate
-22.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QURE uniQure | Downgrades: Market Perform | n/a | $14.77 | - | 2 | Nov 4, 2025 | |
| KYTX Kyverna Therapeutics | Initiates: Outperform | n/a | $7.80 | - | 1 | Aug 20, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Market Perform | n/a | $19.97 | - | 1 | Jun 20, 2025 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Outperform | $65 | $19.38 | +235.40% | 1 | May 28, 2025 | |
| NKTX Nkarta | Downgrades: Market Perform | n/a | $2.06 | - | 1 | May 15, 2025 | |
| TNYA Tenaya Therapeutics | Initiates: Outperform | n/a | $0.67 | - | 1 | Jun 10, 2024 | |
| NGNE Neurogene | Initiates: Outperform | n/a | $20.35 | - | 1 | Mar 21, 2024 | |
| MESO Mesoblast | Downgrades: Market Perform | n/a | $14.36 | - | 1 | Aug 4, 2023 | |
| CRSP CRISPR Therapeutics AG | Reinstates: Outperform | $75 | $45.75 | +63.93% | 1 | May 30, 2023 | |
| LEGN Legend Biotech | Initiates: Market Perform | n/a | $16.80 | - | 1 | May 25, 2023 |
uniQure
Nov 4, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $14.77
Upside: -
Kyverna Therapeutics
Aug 20, 2025
Initiates: Outperform
Price Target: n/a
Current: $7.80
Upside: -
Sarepta Therapeutics
Jun 20, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $19.97
Upside: -
Ultragenyx Pharmaceutical
May 28, 2025
Initiates: Outperform
Price Target: $65
Current: $19.38
Upside: +235.40%
Nkarta
May 15, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $2.06
Upside: -
Tenaya Therapeutics
Jun 10, 2024
Initiates: Outperform
Price Target: n/a
Current: $0.67
Upside: -
Neurogene
Mar 21, 2024
Initiates: Outperform
Price Target: n/a
Current: $20.35
Upside: -
Mesoblast
Aug 4, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $14.36
Upside: -
CRISPR Therapeutics AG
May 30, 2023
Reinstates: Outperform
Price Target: $75
Current: $45.75
Upside: +63.93%
Legend Biotech
May 25, 2023
Initiates: Market Perform
Price Target: n/a
Current: $16.80
Upside: -